About paclitaxel 100 mg
Experience the classic excellence of Paclitaxel 100 mg injection-a lustrous, ready-to-use chemotherapeutic agent designed for the astonishing fight against ovarian, breast, and non-small cell lung cancers, as well as Kaposi's sarcoma. Packaged in a glass, single-use 16.7 ml vial and already in solution, it ensures swift, safe intravenous administration. This scarce reserve of cytotoxic therapy meets rigorous USP standards and is available strictly via prescription. Seize this opportunity during our latest sale-secure reliable cancer care from a trusted Indian supplier.
Paclitaxel 100 mg - Specialized Cancer Care
Paclitaxel 100 mg injection is meticulously formulated for intravenous infusion to target ovarian cancer, breast cancer, non-small cell lung cancer, Kaposi's sarcoma, and various solid tumors. This prescription-only drug acts as a potent cytotoxic antineoplastic agent, disrupting cancer cell proliferation. Its ready-to-infuse, clear-to-pale yellow solution requires no reconstitution and demonstrates reliable compatibility with standard dilution fluids, making it an essential tool in modern oncology therapies.
Packaging, Logistics, and Sample Policy
Each vial of Paclitaxel 100 mg is sealed in a single-use glass container delivering pharmaceutical-grade stability. Shipped goods are securely packaged to comply with recommended storage conditions (20-25C, protected from light) and robust logistics solutions ensure timely shipment worldwide. Sample requests can be accommodated upon agreement, and payment terms are flexible to streamline procurement and distribution, catering to authorized distributors, exporters, and traders looking for efficient supply from India.
FAQ's of paclitaxel 100 mg:
Q: How should Paclitaxel 100 mg be administered?
A: Paclitaxel 100 mg should be administered exclusively as an intravenous (IV) infusion by trained healthcare professionals, following the prescribed dosage and dilution guidelines.
Q: What cancers is Paclitaxel 100 mg indicated for?
A: Paclitaxel 100 mg is approved for the treatment of ovarian cancer, breast cancer, non-small cell lung cancer, Kaposi's sarcoma, and other solid tumors, as prescribed by a physician.
Q: When should Paclitaxel 100 mg be used during cancer therapy?
A: Paclitaxel 100 mg is typically utilized according to a treatment schedule established by an oncologist, often as a first-line or subsequent-line therapy depending on the cancer type and progression.
Q: Where should the vials be stored prior to use?
A: Paclitaxel 100 mg vials must be stored at 20 to 25C (68 to 77F) and protected from light to maintain stability throughout their 24-month shelf life.
Q: What is the process for preparing Paclitaxel 100 mg injection for infusion?
A: No reconstitution is required for Paclitaxel 100 mg; simply dilute the ready-made solution with compatible fluids such as 0.9% sodium chloride or 5% dextrose before administration.
Q: How does Paclitaxel benefit cancer patients?
A: Paclitaxel inhibits cell division in rapidly growing cancer cells, slowing or stopping tumor growth and offering significant therapeutic benefits in the management of multiple solid tumors.